Wednesday, December 07, 2022 12:00:19 AM
Recent GRTS News
- Gritstone bio to Report First Quarter 2024 Financial Results and Provide Corporate Updates on May 9, 2024 • GlobeNewswire Inc. • 05/02/2024 08:05:00 PM
- Gritstone bio Highlights the Durability and Potential Broad Utility of its Self-amplifying mRNA (samRNA) COVID-19 Vaccine at ESCMID Global 2024 • GlobeNewswire Inc. • 04/30/2024 11:00:00 AM
- Gritstone bio Announces Appointment of Stephen Webster to its Board of Directors • GlobeNewswire Inc. • 04/29/2024 11:00:00 AM
- Nature Medicine Publishes Interim Results from Gritstone bio’s Phase 1/2 Study of “Off-the-Shelf” Neoantigen Vaccine Platform (SLATE) • GlobeNewswire Inc. • 04/15/2024 11:00:00 AM
- Gritstone bio to Participate in Upcoming Investor and Scientific Conferences • GlobeNewswire Inc. • 04/08/2024 12:00:00 PM
- Gritstone bio Presents Improvements to EDGE™ Platform at AACR 2024 • GlobeNewswire Inc. • 04/08/2024 11:00:00 AM
- Gritstone bio Announces Pricing of $32.5 Million Underwritten Public Offering • GlobeNewswire Inc. • 04/02/2024 03:00:00 AM
- Gritstone bio Announces Proposed Public Offering • GlobeNewswire Inc. • 04/01/2024 08:10:00 PM
- Gritstone bio Announces Positive Preliminary Progression-free Survival and Long-term Circulating Tumor DNA (ctDNA) Data from Phase 2 Portion of Ongoing Phase 2/3 Study of its Personalized Cancer Vaccine, GRANITE, in Front-line Metastatic Microsatellite Sta • GlobeNewswire Inc. • 04/01/2024 08:01:56 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/05/2024 09:39:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 09:08:45 PM
- Gritstone bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates • GlobeNewswire Inc. • 03/05/2024 09:05:00 PM
- Gritstone bio Announces Workforce Reduction • GlobeNewswire Inc. • 02/29/2024 09:05:00 PM
- Gritstone bio to Participate in Upcoming Investor and Scientific Conferences • GlobeNewswire Inc. • 02/21/2024 12:00:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 05:44:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 12:39:01 PM
- Gritstone bio Announces Update to Comparative Phase 2b COVID-19 Clinical Trial • GlobeNewswire Inc. • 02/12/2024 12:00:00 PM
- Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 02/08/2024 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 12:22:23 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 12:18:36 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 12:14:08 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 12:08:28 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 12:03:48 AM
- Gritstone bio to Participate in Upcoming Investor Conference • GlobeNewswire Inc. • 01/17/2024 12:00:00 PM
- Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 01/10/2024 09:30:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM